Hepatitis C

Payer and Provider Workshops in HCV and HIV (Seattle, WA)

Nov. 14, 2017

Join AGA, PRIME and the Academy of Managed Care Pharmacy at a free dinner program that reflects the most relevant and difficult issues in HCV and HIV treatment and patient management. Identify approaches for better communication and efficient navigation of managed care requirements, and ways to leverage resources that can improve HCV and HIV care.

Payer and Provider Workshops in HCV and HIV (Indianapolis, IN)

Nov. 8, 2017

Join AGA, PRIME and the Academy of Managed Care Pharmacy at a free dinner program that reflects the most relevant and difficult issues in HCV and HIV treatment and patient management. Identify approaches for better communication and efficient navigation of managed care requirements, and ways to leverage resources that can improve HCV and HIV care.

Payer and Provider Workshops in HCV and HIV (Tampa, FL)

Oct. 24, 2017

Join AGA, PRIME and the Academy of Managed Care Pharmacy at a free dinner program that reflects the most relevant and difficult issues in HCV and HIV treatment and patient management. Identify approaches for better communication and efficient navigation of managed care requirements, and ways to leverage resources that can improve HCV and HIV care.

Payer and Provider Workshops in HCV and HIV (Atlanta, GA)

Oct. 12, 2017

Join AGA, PRIME and the Academy of Managed Care Pharmacy at a free dinner program that reflects the most relevant and difficult issues in HCV and HIV treatment and patient management. Identify approaches for better communication and efficient navigation of managed care requirements, and ways to leverage resources that can improve HCV and HIV care.

Payer and Provider Workshops in HCV and HIV (Salt Lake City, UT)

Oct. 11, 2017

Join AGA, PRIME and the Academy of Managed Care Pharmacy at a free dinner program that reflects the most relevant and difficult issues in HCV and HIV treatment and patient management. Identify approaches for better communication and efficient navigation of managed care requirements, and ways to leverage resources that can improve HCV and HIV care.

Payer and Provider Workshops in HCV and HIV (Portland, OR)

Oct. 10, 2017

Join AGA, PRIME and the Academy of Managed Care Pharmacy at a free dinner program that reflects the most relevant and difficult issues in HCV and HIV treatment and patient management. Identify approaches for better communication and efficient navigation of managed care requirements, and ways to leverage resources that can improve HCV and HIV care.

Payer and Provider Workshops in HCV and HIV (Pittsburgh, PA)

Sept. 14, 2017

Join AGA, PRIME and the Academy of Managed Care Pharmacy at a free dinner program that reflects the most relevant and difficult issues in HCV and HIV treatment and patient management. Identify approaches for better communication and efficient navigation of managed care requirements, and ways to leverage resources that can improve HCV and HIV care.
Advertisement

Payer and Provider Workshops in HCV and HIV (Louisville, KY)

Sept. 13, 2017

Join AGA, PRIME and the Academy of Managed Care Pharmacy at a free evening program that reflects the most relevant and difficult issues in HCV and HIV treatment and patient management. Identify approaches for better communication and efficient navigation of managed care requirements, and ways to leverage resources that can improve HCV and HIV care.

Payer and Provider Workshops in HCV and HIV (Chicago, IL)

Sept. 13, 2017

Join AGA, PRIME and the Academy of Managed Care Pharmacy at a free dinner program that reflects the most relevant and difficult issues in HCV and HIV treatment and patient management. Identify approaches for better communication and efficient navigation of managed care requirements, and ways to leverage resources that can improve HCV and HIV care.

Payer and Provider Workshops in HCV and HIV (Los Angeles, CA)

Aug. 29, 2017

Join AGA, PRIME and the Academy of Managed Care Pharmacy at a free evening program that reflects the most relevant and difficult issues in HCV and HIV treatment and patient management. Identify approaches for better communication and efficient navigation of managed care requirements, and ways to leverage resources that can improve HCV and HIV care.

Principles of Gastroenterology for the NP and PA

Aug. 11, 2017

Hear from the experts as they provide you with critical updates on treating and managing patients with a variety of GI disorders.

Latest Issue of AGA Perspectives is Now Available

July 19, 2017

The new issue of AGA Perspectives examines the use of anti-TNF therapy, the promising outlook of stool DNA testing and revisits the gut microbiome of AGA members.

Looking at the Twin Epidemics of HCV

July 6, 2017

Younger cohorts at risk of HCV need more attention.

Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis

June 26, 2017

We performed an open-label, prospective, multicenter study of the effectiveness and tolerance of an all-oral, interferon- and ribavirin-free regimen of sofosbuvir plus daclatasvir in patients with HCV-associated CryoVas.

New WHO Report: More Work Needed to Diagnose, Treat Viral Hepatitis Worldwide

June 22, 2017

Just 20 percent of people with hepatitis C have been diagnosed, and only 7 percent have been treated.

Member Benefit Spotlight: GastroSlides

June 15, 2017

Free access to AGA's GastroSlides is now a member benefit.

Course for NPs and PAs Benefits All Experience Levels

June 14, 2017

Find out how AGA's popular course, Principles of GI for the NP and PA, benefits all those who attend, regardless of experience level or practice setting.

Canadian HCV Screening Guidelines Do Not Include Baby Boomers

June 8, 2017

Controversial guidelines spark debate.

AGA Releases New HCV Care Pathway

June 6, 2017

The AGA Hepatitis C Virus (HCV) Infection Care Pathway provides guidance regarding the best practices for managing U.S.-based patients with HCV.

Direct-Acting Antiviral Agents for Patients With Hepatitis C Virus Genotype 1 Infection Are Cost-Saving

June 1, 2017

We found treatment of HCV genotype 1 infection with second-generation DAAs to be cost-effective when they cost less than and $227,200.

Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus–Induced Cryoglobulinemia Vasculitis

June 1, 2017

We analyzed blood samples from patients with HCV-CV before and after DAA therapy to determine mechanisms of these drugs and their effects on cellular immunity.

New Hepatitis C Treatment Not Linked to Liver Cancer

May 25, 2017

Contrary to some earlier research, most recent studies see no association between response to DAAs and HCC.

HCV Rare in Kids; Treatment Isn't Straightforward

May 11, 2017

DAAs may be around the corner for children, but many considerations remain. More insights in this AGA-MedPage Today Reading Room article.

Digestive Disease Week® (DDW)

May 6, 2017

Digestive Disease Week® (DDW) is the premier meeting for the GI professional. Every year it attracts approximately 15,000 physicians, researchers and academics from around the world who desire to stay up-to-date in the field.